Insider Transactions in Q3 2025 at I Teos Therapeutics, Inc. (ITOS)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 29
2025
|
Yvonne Mc Grath Chief Scientific Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
46,300
-100.0%
|
-
|
|
Aug 29
2025
|
Matthew Gall Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
89,429
-100.0%
|
-
|
|
Aug 29
2025
|
David Feltquate Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
47,000
-100.0%
|
-
|
|
Aug 29
2025
|
Michel Detheux Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
94,027
-100.0%
|
-
|
|
Aug 29
2025
|
Michel Detheux Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
153,903
-100.0%
|
-
|
|
Aug 29
2025
|
Matthew Call Chief Operating Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
161,898
-100.0%
|
-
|